Feedback / Questions
PTT-4256 - Pathios Therap
https://www.prnewswire.com/news-releases/pathios-therapeutics-announces-dosing-of-first-patient-in-phase-12-clinical-study-of-gpr65-inhibitor-ptt-4256-in-patients-with-advanced-solid-cancers-302310915.html
Nov 20, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next